Xiaorong Shui

机构：Guangdong Medical College, Beijing University of Chinese Medicine, Affiliated Hospital of Guangdong Medical College Hospital · ORCID：0009-0003-1389-4488

发表论文 39 篇 · 总被引 685 次 · h-index 14

代表论文

• Aryl Hydrocarbon Receptor: A New Player of Pathogenesis and Therapy in Cardiovascular Diseases (2018 · BioMed Research International · 被引 70)
• Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review) (2020 · International Journal of Molecular Medicine · 被引 58)
• The potential relationship of coronary artery disease and hyperuricemia: A cardiometabolic risk factor (2023 · Heliyon · 被引 37)
• Baicalin prevents pulmonary arterial remodeling in vivo via the AKT/ERK/NF‐κB signaling pathways (2019 · Pulmonary Circulation · 被引 22)
• ITE promotes hypoxia‐induced transdifferentiation of human pulmonary arterial endothelial cells possibly by activating transforming growth factor‐β/Smads and MAPK/ERK pathways (2019 · Journal of Cellular Biochemistry · 被引 21)
• Insights into the relationship between serum uric acid and pulmonary hypertension (Review) (2023 · Molecular Medicine Reports · 被引 19)